Alnylam Patient Education Liaisons (PELs) are professionals with backgrounds in nursing who can provide education to you and your family about hATTR amyloidosis and treatment with AMVUTTRA™, a prescription medicine that treats the polyneuropathy caused by hATTR amyloidosis in adults.
The purpose of the Alnylam Patient Education Liaison (PEL) team is to provide education to patients, their families, and caregivers.
- PELs engage with patients one-on-one to provide education, participate in family meetings, and help raise awareness about hATTR amyloidosis in community health organizations
- PELs are employees of Alnylam Pharmaceuticals. They are not acting as healthcare providers and are not part of your healthcare team
- PELs do not provide medical care or advice
- All diagnosis and treatment decisions should be made by you and your doctor